John Sperzel III Net Worth & Insider Trades

John Sperzel III - Chairman, T2 Biosystems, Inc

As of April 11, 2022

What is John Sperzel III's Net Worth?

The current estimated net worth of T2 Biosystems, Inc's Chairman, John Sperzel III, is estimated to be about $376.33K . John Sperzel III owns about 221,773 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, John Sperzel III has sold an estimated value of $63.53K worth.

What is John Sperzel III's Past Insider Trading?

John Sperzel III's largest purchase order was 30,000 units , worth over $15K on April 11, 2022. In total, John Sperzel III has made about 4 transactions over a year of their time at T2 Biosystems, Inc. John Sperzel III usually trades in February, with the busiest year in 2022.

John Sperzel III

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was John Sperzel III's Salary in 2020?

As Chairman of T2 Biosystems, Inc, John Sperzel III has a total base salary of $72,906 . John Sperzel III received compensation valued at about $1,170,087 in 2020 after becoming Chairman. The vast majority of their compensation came in the form of stock awards of $74,999 , other compensation of $1,022,182 .

What is John Sperzel III's' Mailing Address?

  • Mailing address is 61 Crestview Lane Brunswick ME 04011 ME

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

What are T2 Biosystems, Inc's Past Insider Trades?

T2 Biosystems, Inc's most recent insider trade came on November 22, 2022 by Brett Giffin who sold 1,292 units worth $2.32K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and Terrence Michael Gibbs, General Counsel .

T2 Biosystems, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1